|
Complimentary CME/CE/CPEU Meetings Coming to Atlanta, GA, Baltimore, MD, Columbus, OH, Houston, TX, Philadelphia, PA, Phoenix, AZ, Raleigh/Durham, NC, and Tampa, FL
BALTIMORE, Md.—March 2, 2012— Diabetes is a worldwide epidemic that affects 25.8 million people of all ages. It is the leading cause of kidney failure, nontraumatic lower-limb amputations, and new cases of blindness among adults in the United States; it is also a major cause of heart disease and stroke.
Healthcare professionals in primary care play a central role in the management of this condition, providing care for up to 95% of adults with type 2 diabetes. A patient with diabetes has high blood sugar, caused when the body does not produce enough insulin or when cells do not respond to the insulin that is produced by the pancreas. Insulin is an essential hormone produced by the body to regulate carbohydrate and fat metabolism. Patients with type 2 diabetes frequently require the use of injected insulin therapy to adequately control their blood sugar.
For patients with type 2 diabetes, starting and using insulin can be complex, especially because insulin requires a patient to inject oneself. For clinicians, transitioning patients onto insulin therapy is also complex.
"The integration of insulin into the management of type 2 diabetes should be a team-effort," said William A. Mencia, MD, CCMEP, Vice President of Education and Medical Affairs at Med-IQ, America’s most respected continuing medical education company. "The complexities of starting insulin may be lessened with the integration of new delivery methods shown to be accurate and effective with a positive impact on patient adherence and satisfaction."
Healthcare professionals must understand and address clinician and patient factors that lead to clinical inertia and psychological insulin resistance and develop strategies to overcome these barriers. They must also work collaboratively with patients to achieve optimal glycemic control.
"Education that strengthens patient-provider collaboration and shared decision-making is important to overcome clinical challenges and improve patient outcomes," said Laura M. Downes, CAE, Chief Operating Officer of the American Association of Diabetes Educators (AADE).
To help diabetes care teams address these factors before initiating insulin and throughout the course of treatment, Med-IQ and AADE are providing a series of live, interactive workshops that bring primary healthcare professionals and patients together to engage in a face-to-face exchange on perceptions and barriers related to initiating insulin and using insulin pens in the management of type 2 diabetes.
Finding Common Ground in the Use of Insulin Pens: A Patient-Provider Exchange on Barriers and Solutions will help physicians, physician assistants, nurse practitioners, nurses, registered dietitians, and dietetic technicians formulate strategies to support the appropriate implementation of these devices into practice, foster effective communication to help overcome psychological insulin resistance, and reinforce patient and physician acceptance of this treatment modality.
Primary care professionals are invited to attend the complimentary CME/CE/CPE workshops in the following cities:
- Atlanta, GA—April 25, 2012, 200 Peachtree Special Events & Conference Center
- Baltimore, MD—March 14, 2012, Baltimore Marriott Waterfront
- Columbus, OH—April 4, 2012, The Westin Columbus
- Houston, TX—March 21, 2012, The Houstonian
- Philadelphia, PA—March 28, 2012, The Hub Cira Centre
- Phoenix, AZ—May 9, 2012, Pointe Hilton Squaw Peak
- Raleigh/Durham, NC—May 2, 2012, Washington Duke Inn
- Tampa, FL—April 18, 2012, Renaissance Tampa International Plaza Hotel
Meetings will be held from 7:00 to 8:45 AM, and breakfast will be served. This activity has been approved for AMA PRA Category 1 Credit™. Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.75 continuing professional education units (CPEUs) for completion of this program.
| FACULTY ADVISORS |
| |
Timothy S. Reid, MD
Director
Mercy Diabetes Center
Janesville, WI
|
|
| |
Donna Rice, MBA, RN, CDE, FAADE
President, Diabetes Health & Wellness Institute
Baylor Health Care System
Dallas, TX
|
|
|
|
"Achieving adequate glycemic control is one of the cornerstones of preventing diabetes-related complications and early death. Furthermore, patient participation in the management of this progressive disease is essential for success," said Dr. Mencia.
Frontline perspectives and key teaching points gained at these live meetings will be incorporated into an enduring Web-based activity designed to help educate all practitioners who manage patients with type 2 diabetes.
This activity is supported by an educational grant from Sanofi-aventis U.S., Inc. A SANOFI COMPANY. For more information, call (toll-free) 866 858 7434 or e-mail info@med-iq.com.
About Med-IQ
Med-IQ, America’s most respected provider of continuing medical education (CME), inspires healthcare professionals through activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ received the Alliance for Continuing Education in the Health Professions' President’s Award (2012), Award for Outstanding CME Outcomes Assessment (2012), and William Campbell Felch Award for Outstanding Research in CME (2011). Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively. We are a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives. To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, connect with us on LinkedIn, and visit our YouTube channel.
For more information, contact:
|
close
